These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 3469747)

  • 1. Alteration of the body flora by antibiotics--can it be avoided?
    Geddes AM
    Scand J Infect Dis Suppl; 1986; 49():131-4. PubMed ID: 3469747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appropriate category of isolation for antibiotic resistant organisms.
    Gurevich I; Yannelli B; Cunha BA
    Infect Control; 1987 Oct; 8(10):400-2. PubMed ID: 3667115
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting. World Health Organization Scientific Working Group on Antimicrobial Resistance.
    Am J Hosp Pharm; 1984 Jul; 41(7):1329-37. PubMed ID: 6540519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecological antibiotic policy.
    Høiby N
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():59-62; discussion 63-5. PubMed ID: 11051626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for prevention and control of multiple drug-resistant nosocomial infection.
    Weinstein RA; Kabins SA
    Am J Med; 1981 Feb; 70(2):449-54. PubMed ID: 7468626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance.
    Colgan R; Powers JH
    Am Fam Physician; 2001 Sep; 64(6):999-1004. PubMed ID: 11578036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better control of antibiotic resistance.
    Guillemot D; Courvalin P;
    Clin Infect Dis; 2001 Aug; 33(4):542-7. PubMed ID: 11462192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change of bacterial flora during chemotherapy (author's transl)].
    Knothe H
    MMW Munch Med Wochenschr; 1976 Apr; 118(17):521-4. PubMed ID: 818522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of bacterial resistance to antibiotics (author's transl)].
    Schito GC
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():444-58. PubMed ID: 555526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of antibiotic resistance in European ICUs.
    Hanberger H; Diekema D; Fluit A; Jones R; Struelens M; Spencer R; Wolff M
    J Hosp Infect; 2001 Jul; 48(3):161-76. PubMed ID: 11439002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What therapeutic possibilities exist in acute antibiotic-resistant and chronic infections].
    Seifert J; Duswald KH; Lob G
    Fortschr Med; 1982 Apr; 100(13):592-8. PubMed ID: 6178664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are isolation measures needed in the hospital management of Acinetobacter baumannii colonizations-infections?].
    Gbaguidi Haore H; Bertrand X; Muller A; Thouverez M; Talon D
    Med Mal Infect; 2006 Apr; 36(4):201-6. PubMed ID: 16580163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance.
    WHO Scientific Working Group
    Bull World Health Organ; 1983; 61(3):383-94. PubMed ID: 6603914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the emergence of bacterial resistance in the hospital environment.
    Hosein IK; Hill DW; Jenkins LE; Magee JT
    J Appl Microbiol; 2002; 92 Suppl():90S-7S. PubMed ID: 12000618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
    Klastersky J
    Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.